mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.5 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.6 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.6 |